NewAmsterdam COO's $1.9M Stock Sale: What Investors Should Know
Rhea-AI Filing Summary
Douglas F. Kling, Chief Operating Officer of NewAmsterdam Pharma, reported significant insider transactions on June 16, 2025:
- Exercised stock options to acquire 100,000 total ordinary shares: - 78,101 shares at $10.00 per share - 21,899 shares at $10.90 per share
- Subsequently sold 100,000 shares in two tranches: - 81,891 shares at weighted average price of $19.19 - 18,109 shares at weighted average price of $19.75
- Post-transactions, Kling retains: - 44,000 ordinary shares - 372,829 options at $10.00 strike price - 261,314 options at $10.90 strike price
The transactions were executed under a Rule 10b5-1 trading plan. The sales represent a partial liquidation of Kling's holdings while maintaining significant equity exposure through remaining shares and options.
Positive
- None.
Negative
- COO Douglas Kling executed a significant net sale of 100,000 shares (~69% of post-exercise holdings) at prices between $18.60-$20.21, retaining only 44,000 shares
Insider Trade Summary
Exercise and Sale: 100,000 shares ($909K approx. pre-tax spread)
Exercise and Sale
6 txns
Insider
Kling Douglas F
Role
Chief Operating Officer
Sold
100,000 shs ($1.93M)
Approx. gross sale proceeds
$1.93M
Approx. exercise cost
$1.02M
Approx. pre-tax spread
$909K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (right to buy) | 78,101 | $0.00 | $0.00 |
| Exercise | Option (right to buy) | 21,899 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 78,101 | $10.00 | $781K |
| Exercise | Ordinary Shares | 21,899 | $10.90 | $239K |
| Sale | Ordinary Shares | 81,891 | $19.19 | $1.57M |
| Sale | Ordinary Shares | 18,109 | $19.75 | $358K |
Holdings After Transaction:
Option (right to buy) — 634,143 shares (Direct);
Ordinary Shares — 44,000 shares (Direct)
Footnotes (5)
- F1. This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.60 per share to $19.59 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.60 per share to $20.21 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
- F4. The option was granted on November 22, 2022. The shares underlying the option vest in equal monthly installments over four years, with the first 1/48th of such shares vesting on December 22, 2022 and the remaining installments vesting on each one-month anniversary of the grant date, subject to the Reporting Person's continued service through each such date.
- F5. The option was granted on January 1, 2023. 25% of the shares underlying the option vested on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What was the exercise price of NAMSW stock options exercised by Douglas Kling?
Douglas Kling exercised two sets of stock options: 78,101 shares at an exercise price of $10.00 and 21,899 shares at an exercise price of $10.90.
Was Douglas Kling's NAMSW stock sale part of a 10b5-1 trading plan?
Yes, the filing explicitly states that the transactions were effected pursuant to a trading plan adopted by Douglas Kling in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
What is the vesting schedule for Douglas Kling's NAMSW stock options?
The $10.00 options granted on November 22, 2022 vest monthly over 4 years (1/48th per month), starting December 22, 2022. The $10.90 options granted on January 1, 2023 vest 25% after one year, with the remainder vesting monthly over the following three years.